From the American College of Rheumatology In a significant and dangerous departure from previous policy, the Centers for Medicare and Medicaid Services (CMS) will begin adjusting Part B drug reimbursements to physicians based on their performance in the Merit-based Incentive
Take Action (September 2017)
Physicians across the country are concerned about keeping the Centers for Medicare & Medicaid Services from imposing quality-program penalties and bonuses on Part B drug payments. Across the country, physicians are urging Congress to oppose this proposal, which could compel
New opioid clinical policy (effective October 1, 2017)
Washington State Healthcare Authority Announcement: Healthcare providers should be aware that on October 1, 2017, a new Washington State Health Care Authority (HCA) clinical policy pertaining to opioid prescriptions takes effect for Apple Health (Medicaid), both through managed care organizations
Advocacy-Related Requests for WRA Members
Adam Cooper, Senior Director, Government Affairs, American College of Rheumatology, attended our 2016 WRA Annual Conference and asked us to pass on these advocacy-related requests to our members: 1. We are asking members to join or renew their AMA memberships
WRA Advocacy News – June 2016
State Updates Washington Out-of-Pocket Costs Taskforce Selected The July 1st deadline is approaching to convene the first Out-of-Pocket Costs Taskforce meeting that was created by Senate Bill 6569 this past spring. Joanna Lindsay from the Arthritis Foundation, and Stephanie Simpson
WRA Advocacy News – April 2016
State Updates Senate Bill 6569 (Out-of-Pocket Task Force) SB 6569 was an initiative that passed into law by a veto override vote during a special session that adjourned in March to end the two-year legislative cycle (2015-2016). The bill creates